Skip to main content

Table 3 Prescribed medicines for COPD patients

From: A short-term educational program improved physicians’ adherence to guidelines for COPD and asthma in Shanghai

  GOLD II GOLD III GOLD IV Total
  (n = 12) (n = 21) (n = 10) (n = 43)
Short acting bronchodilator 75.0% 80.9% 80.0% 79.1%
Combined LABA with steroid 58.3% 61.9% 70.0% 62.8%
Antibiotics 58.3% 61.9% 60.0% 60.5%
Expectorants 50% 52.4% 70.0% 55.8%
Combined ≥2 bronchodilators 50.% 76.2% 70.0% 67.4%
Long acting bronchodilator 16.7% 9.5% 20.0% 14.0%
Anti-tussive 8.3% 47.6% 10.0% 27.9%
Chinese traditional medicine 8.3% 19.1% 20.0% 16.3%
Oral corticosteroids 0.0% 14.3% 0.0% 7.0%
ICS 0.0% 0% 10.0% 2.3%